167 related articles for article (PubMed ID: 18219813)
1. Pathological heterogeneity of idiopathic central nervous system inflammatory demyelinating disorders.
Lucchinetti C
Curr Top Microbiol Immunol; 2008; 318():19-43. PubMed ID: 18219813
[TBL] [Abstract][Full Text] [Related]
2. The pathological spectrum of CNS inflammatory demyelinating diseases.
Hu W; Lucchinetti CF
Semin Immunopathol; 2009 Nov; 31(4):439-53. PubMed ID: 19779719
[TBL] [Abstract][Full Text] [Related]
3. Pathology of multiple sclerosis and related inflammatory demyelinating diseases.
Kutzelnigg A; Lassmann H
Handb Clin Neurol; 2014; 122():15-58. PubMed ID: 24507512
[TBL] [Abstract][Full Text] [Related]
4. Pathology of demyelinating diseases.
Popescu BF; Lucchinetti CF
Annu Rev Pathol; 2012; 7():185-217. PubMed ID: 22313379
[TBL] [Abstract][Full Text] [Related]
5. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
Lassmann H
Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
[TBL] [Abstract][Full Text] [Related]
6. The role of oligodendrocytes and oligodendrocyte progenitors in CNS remyelination.
Keirstead HS; Blakemore WF
Adv Exp Med Biol; 1999; 468():183-97. PubMed ID: 10635029
[TBL] [Abstract][Full Text] [Related]
7. Multiple sclerosis: lessons from neuropathology.
Lucchinetti CF; Brueck W; Rodriguez M; Lassmann H
Semin Neurol; 1998; 18(3):337-49. PubMed ID: 9817538
[TBL] [Abstract][Full Text] [Related]
8. MRI evidence for multiple sclerosis as a diffuse disease of the central nervous system.
Filippi M; Rocca MA
J Neurol; 2005 Nov; 252 Suppl 5():v16-24. PubMed ID: 16254697
[TBL] [Abstract][Full Text] [Related]
9. Lessons from the neuropathology of atypical forms of multiple sclerosis.
Stadelmann C; Brück W
Neurol Sci; 2004 Nov; 25 Suppl 4():S319-22. PubMed ID: 15727225
[TBL] [Abstract][Full Text] [Related]
10. Morphology of demyelination in the human central nervous system.
Hauw JJ; Delaère P; Seilhean D; Cornu P
J Neuroimmunol; 1992 Oct; 40(2-3):139-52. PubMed ID: 1430147
[TBL] [Abstract][Full Text] [Related]
11. Multiple sclerosis, and other demyelinating and autoimmune inflammatory diseases of the central nervous system.
Matute-Blanch C; Montalban X; Comabella M
Handb Clin Neurol; 2017; 146():67-84. PubMed ID: 29110780
[TBL] [Abstract][Full Text] [Related]
12. Clinical course, pathological correlations, and outcome of biopsy proved inflammatory demyelinating disease.
Pittock SJ; McClelland RL; Achenbach SJ; Konig F; Bitsch A; Brück W; Lassmann H; Parisi JE; Scheithauer BW; Rodriguez M; Weinshenker BG; Lucchinetti CF
J Neurol Neurosurg Psychiatry; 2005 Dec; 76(12):1693-7. PubMed ID: 16291895
[TBL] [Abstract][Full Text] [Related]
13. Inflammation, demyelination, and degeneration - recent insights from MS pathology.
Stadelmann C; Wegner C; Brück W
Biochim Biophys Acta; 2011 Feb; 1812(2):275-82. PubMed ID: 20637864
[TBL] [Abstract][Full Text] [Related]
14. Evidence for central nervous system demyelination in chronic inflammatory demyelinating polyradiculoneuropathy.
Mendell JR; Kolkin S; Kissel JT; Weiss KL; Chakeres DW; Rammohan KW
Neurology; 1987 Aug; 37(8):1291-4. PubMed ID: 3614649
[TBL] [Abstract][Full Text] [Related]
15. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis.
Meinl E; Krumbholz M; Derfuss T; Junker A; Hohlfeld R
J Neurol Sci; 2008 Nov; 274(1-2):42-4. PubMed ID: 18715571
[TBL] [Abstract][Full Text] [Related]
16. Multiple Sclerosis Pathology.
Lassmann H
Cold Spring Harb Perspect Med; 2018 Mar; 8(3):. PubMed ID: 29358320
[TBL] [Abstract][Full Text] [Related]
17. Central nervous system inflammation across the age span.
Bar-Or A; Antel JP
Curr Opin Neurol; 2016 Jun; 29(3):381-7. PubMed ID: 27035901
[TBL] [Abstract][Full Text] [Related]
18. Progress in understanding the pathophysiology of multiple sclerosis.
Zéphir H
Rev Neurol (Paris); 2018 Jun; 174(6):358-363. PubMed ID: 29680179
[TBL] [Abstract][Full Text] [Related]
19. Pathology of multiple sclerosis: where do we stand?
Popescu BF; Pirko I; Lucchinetti CF
Continuum (Minneap Minn); 2013 Aug; 19(4 Multiple Sclerosis):901-21. PubMed ID: 23917093
[TBL] [Abstract][Full Text] [Related]
20. Review: the architecture of inflammatory demyelinating lesions: implications for studies on pathogenesis.
Lassmann H
Neuropathol Appl Neurobiol; 2011 Dec; 37(7):698-710. PubMed ID: 21696413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
